TrialBMJ open2016

Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study.

Rachel T McGrath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.